| 1 | Prevalence and Predictors of Follow-up Endoscopic Biopsy in Patients With Celiac Disease in the United States | 2.2 | 0 | Citations (PDF) |
| 2 | Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program study | 2.4 | 14 | Citations (PDF) |
| 3 | Assessment of early‐death in gynecologic malignancy in the United States | 1.8 | 1 | Citations (PDF) |
| 4 | Transverse versus Vertical Incision in the Surgical Management of Placenta Accreta Spectrum | 1.7 | 0 | Citations (PDF) |
| 5 | Patient and Surgeon Attitudes Toward Opportunistic Salpingectomy During Nongynecological Surgeries for the Prevention of Ovarian Cancer: A Qualitative Study | 1.5 | 1 | Citations (PDF) |
| 6 | Trends and comparisons of palliative care utilization for patients with metastatic gynecologic malignancy | 2.7 | 2 | Citations (PDF) |
| 7 | Estimating high-grade serous fallopian tubal carcinoma in the era of tubal hypothesis | 2.7 | 2 | Citations (PDF) |
| 8 | Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer | 3.0 | 2 | Citations (PDF) |
| 9 | Temporal Trends And Outcomes Of Sentinel Lymph Node Biopsy For Cervical Cancer In The United States | 2.7 | 0 | Citations (PDF) |
| 10 | Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals | 3.0 | 2 | Citations (PDF) |
| 11 | How to talk with surgical patients about risk: The example of a novel surgical strategy | 3.3 | 0 | Citations (PDF) |
| 12 | Examining the Association of Body Mass Index and Complications When Including Sentinel Lymph Node Biopsy in Minimally Invasive Surgery for Endometrial Intraepithelial Neoplasia | 3.8 | 0 | Citations (PDF) |
| 13 | Peer influence on physicians in adopting opportunistic salpingectomy at the time of hysterectomy | 2.4 | 0 | Citations (PDF) |
| 14 | Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical cancer surgery | 3.0 | 4 | Citations (PDF) |
| 15 | Nationwide assessment of COVID-19 ventilator and non-invasive respiratory support burden during the early pandemic in the United States | 3.4 | 0 | Citations (PDF) |
| 16 | Cytology-negative, non-myoinvasive stage IC serous endometrial cancer: Assessment of adjuvant chemotherapy omission | 3.0 | 1 | Citations (PDF) |
| 17 | Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States | 1.1 | 2 | Citations (PDF) |
| 18 | Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2) | 3.0 | 1 | Citations (PDF) |
| 19 | Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery | 1.4 | 1 | Citations (PDF) |
| 20 | Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability | 3.0 | 2 | Citations (PDF) |
| 21 | Risk for and temporal trends in cesarean surgical complications | 1.7 | 3 | Citations (PDF) |
| 22 | Longitudinal Risk Adjustment for Maternal End-Organ Injury and Death | 1.7 | 1 | Citations (PDF) |
| 23 | Maternal morbidity and mortality associated with epilepsy | 1.7 | 12 | Citations (PDF) |
| 24 | Pregnancy costs with commercial insurance | 1.7 | 2 | Citations (PDF) |
| 25 | Trends in tubal sterilisation in young women in the United States | 3.1 | 1 | Citations (PDF) |
| 26 | Ambient particulate matter air pollution exposure and ovarian cancer incidence in the USA: An ecological study | 3.1 | 12 | Citations (PDF) |
| 27 | Racial and Ethnic Disparities in the Use of Robot-Assisted Surgery and Minimally Invasive Surgery in Pelvic Cancer Treatment: A Systematic Review | 1.1 | 5 | Citations (PDF) |
| 28 | Black-White differences in uterine cancer symptomatology and stage at diagnosis | 3.0 | 10 | Citations (PDF) |
| 29 | Regional Variation in Antenatal Late Preterm Steroid Use Following the ALPS Trial | 6.6 | 5 | Citations (PDF) |
| 30 | Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States | 4.4 | 14 | Citations (PDF) |
| 31 | Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy | 4.9 | 8 | Citations (PDF) |
| 32 | Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause | 2.4 | 3 | Citations (PDF) |
| 33 | Nationwide assessment of practice variability in the utilization of hysteropexy at laparoscopic apical suspension for uterine prolapse | 1.3 | 2 | Citations (PDF) |
| 34 | Racial and ethnic differences in early death among gynecologic malignancy | 2.4 | 6 | Citations (PDF) |
| 35 | Lymph Node Isolated Tumor Cells in Patients With Endometrial Cancer | 6.6 | 11 | Citations (PDF) |
| 36 | Increasing utilization of intrauterine device insertion at hysteroscopic endometrial evaluation for patients with endometrial hyperplasia | 1.9 | 1 | Citations (PDF) |
| 37 | Comparing survival of older ovarian cancer patients treated with neoadjuvant chemotherapy versus primary cytoreductive surgery: Reducing bias through machine learning | 3.0 | 7 | Citations (PDF) |
| 38 | Cesarean hysterectomy for placenta accreta spectrum: Surgeon specialty-specific assessment | 3.0 | 5 | Citations (PDF) |
| 39 | Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention | 2.4 | 9 | Citations (PDF) |
| 40 | Prognostic performance of the 2023 FIGO staging schema for endometrial cancer | 3.0 | 21 | Citations (PDF) |
| 41 | Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects | 3.0 | 9 | Citations (PDF) |
| 42 | Incidence of induced abortion among commercially insured pregnant patients with cancer | 1.2 | 1 | Citations (PDF) |
| 43 | Patterns of use of primary and first-line chemotherapy for recurrence among patients with cervical cancer | 2.7 | 1 | Citations (PDF) |
| 44 | Sociodemographic factors associated with antenatal steroid use among late preterm births | 2.1 | 2 | Citations (PDF) |
| 45 | Primary Cytoreduction and Survival for Patients With Less-Common Epithelial Ovarian Cancer | 6.6 | 4 | Citations (PDF) |
| 46 | Temporal trends of adolescents and young adults (AYA) with gynecologic malignancy in the United States | 0.7 | 0 | Citations (PDF) |
| 47 | Fragmented Surgical Cancer Care—A Growing Divide | 3.0 | 0 | Citations (PDF) |
| 48 | Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis | 2.4 | 15 | Citations (PDF) |
| 49 | Incorporation of immunotherapy and biological targeted therapy in primary anti‐cancer treatment in gynecologic malignancy | 1.8 | 0 | Citations (PDF) |
| 50 | Secondary databases in gynecologic cancer research | 2.7 | 22 | Citations (PDF) |
| 51 | Racial and ethnic disparities in robot-assisted radical prostatectomy: testing the physician-level segregated and differential treatment hypotheses | 2.9 | 2 | Citations (PDF) |
| 52 | Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation | 2.7 | 2 | Citations (PDF) |
| 53 | Antihypertensive medication prescription dispensation among pregnant women in the United States: A cohort study | 2.9 | 1 | Citations (PDF) |
| 54 | Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer | 3.0 | 2 | Citations (PDF) |
| 55 | Tubal Sterilization Rates by State Abortion Laws After the Dobbs Decision | 16.6 | 17 | Citations (PDF) |
| 56 | Diagnostic experiences of Black and White patients with uterine cancer: A qualitative study | 3.0 | 2 | Citations (PDF) |
| 57 | Risk factors for major complications following pelvic exenteration: A NSQIP study | 0.9 | 4 | Citations (PDF) |
| 58 | Adjuvant therapy de-escalation for stage I uterine leiomyosarcoma: A systematic review and meta-analysis | 3.0 | 4 | Citations (PDF) |
| 59 | Suicide Deaths Among Adolescent and Young Adult Patients With Cancer | 6.6 | 3 | Citations (PDF) |
| 60 | Postthrombotic Syndrome and Chronic Pulmonary Embolism after Obstetric Venous Thromboembolism | 1.7 | 1 | Citations (PDF) |
| 61 | Prevalence of anxiety and depressive disorders in pregnant women with malignancy | 1.8 | 4 | Citations (PDF) |
| 62 | Association between neighborhood socioeconomic status, built environment and SARS‐CoV‐2 infection among cancer patients treated at a Tertiary Cancer Center in New York City | 1.7 | 3 | Citations (PDF) |
| 63 | Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs | 3.0 | 5 | Citations (PDF) |
| 64 | Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause | 2.7 | 10 | Citations (PDF) |
| 65 | Risk for adverse maternal outcomes among women with chronic hypertension | 3.1 | 0 | Citations (PDF) |
| 66 | Medical and surgical retreatment for uterine leiomyoma after myomectomy | 3.1 | 0 | Citations (PDF) |
| 67 | Intraoperative rupture and chemotherapy use in stage I ovarian cancer | 0.9 | 2 | Citations (PDF) |
| 68 | Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries | 4.6 | 18 | Citations (PDF) |
| 69 | The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research | 2.5 | 8 | Citations (PDF) |
| 70 | A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies | 25.1 | 32 | Citations (PDF) |
| 71 | Direct oral anticoagulant (DOACs) prescribing practices of members of the Society of Gynecologic Oncology and American Society of Clinical Oncology | 3.0 | 2 | Citations (PDF) |
| 72 | Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting | 2.3 | 7 | Citations (PDF) |
| 73 | Cancer‐directed surgery in patients with metastatic cancer: A systematic review and meta‐analysis of randomized evidence | 2.6 | 5 | Citations (PDF) |
| 74 | Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas | 6.6 | 19 | Citations (PDF) |
| 75 | Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer | 3.0 | 6 | Citations (PDF) |
| 76 | Trends in the use of indocyanine green for sentinel lymph node mapping in vulvar cancer | 2.4 | 4 | Citations (PDF) |
| 77 | Temporal trends of failure-to-rescue following perioperative complications in vulvar cancer surgery in the United States | 3.0 | 3 | Citations (PDF) |
| 78 | Placenta previa percreta with surrounding organ involvement: a proposal for management | 2.7 | 11 | Citations (PDF) |
| 79 | National Estimates of Gender-Affirming Surgery in the US | 6.6 | 141 | Citations (PDF) |
| 80 | Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta-analysis | 2.9 | 22 | Citations (PDF) |
| 81 | Trends, Characteristics, and Maternal Morbidity Associated With Unhoused Status in Pregnancy | 6.6 | 32 | Citations (PDF) |
| 82 | Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial | 22.9 | 41 | Citations (PDF) |
| 83 | Risk factors for developing both primary breast and primary ovarian cancer: A systematic review | 5.0 | 12 | Citations (PDF) |
| 84 | Timeliness of diagnostic evaluation for postmenopausal bleeding: A retrospective cohort study using claims data | 2.3 | 4 | Citations (PDF) |
| 85 | Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer | 2.4 | 0 | Citations (PDF) |
| 86 | Validation of the 2023 FIGO staging schema for advanced endometrial cancer | 4.9 | 26 | Citations (PDF) |
| 87 | TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes | 3.0 | 30 | Citations (PDF) |
| 88 | Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-Prostatectomy Outcomes Among Prostate Cancer Patients | 2.3 | 3 | Citations (PDF) |
| 89 | Trends in Cancer-Directed Surgery Rates Associated with the COVID-19 Pandemic | 2.3 | 0 | Citations (PDF) |
| 90 | Decision to Incision and Risk for Fetal Acidemia, Low Apgar Scores, and Hypoxic Ischemic Encephalopathy | 1.7 | 5 | Citations (PDF) |
| 91 | Vancomycin during delivery hospitalizations for women with group B streptococcus | 1.7 | 1 | Citations (PDF) |
| 92 | Endometrial Sampling for Preoperative Diagnosis of Uterine Leiomyosarcoma | 0.8 | 10 | Citations (PDF) |
| 93 | Trends in and complications associated with mental health condition diagnoses during delivery hospitalizations | 2.4 | 31 | Citations (PDF) |
| 94 | Postpartum cardiac readmissions among women without a cardiac diagnosis at delivery | 1.7 | 5 | Citations (PDF) |
| 95 | Minimally invasive surgery for suspected early‐stage ovarian cancer; a cost‐effectiveness study | 3.1 | 11 | Citations (PDF) |
| 96 | Comparison of Perioperative Outcomes in Heart Failure Patients With Reduced Versus Preserved Ejection Fraction After Noncardiac Surgery | 4.6 | 13 | Citations (PDF) |
| 97 | Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United States | 3.0 | 17 | Citations (PDF) |
| 98 | Hospital surgical volume–outcome relationship in caesarean hysterectomy for placenta accreta spectrum | 3.1 | 16 | Citations (PDF) |
| 99 | Long-term outcomes of vaginal hysterectomy for endometrial cancer | 3.0 | 3 | Citations (PDF) |
| 100 | Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City | 14.4 | 14 | Citations (PDF) |
| 101 | Perioperative and persistent opioid utilization following pancreatectomy in the United States | 0.3 | 3 | Citations (PDF) |
| 102 | Adverse Outcomes during Postpartum Readmissions after Deliveries Complicated by Hypertensive Disorders of Pregnancy | 1.7 | 15 | Citations (PDF) |
| 103 | Out-of-network bills among privately insured patients undergoing hysterectomy | 2.4 | 4 | Citations (PDF) |
| 104 | Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer | 1.9 | 2 | Citations (PDF) |
| 105 | Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States | 3.0 | 7 | Citations (PDF) |
| 106 | Validation of the 2021 FIGO staging schema for advanced vulvar cancer | 2.7 | 6 | Citations (PDF) |
| 107 | Authors' reply re: Covariate analysis query: Hospital surgical volume‐outcome relationship in caesarean hysterectomy for placenta accreta spectrum | 3.1 | 0 | Citations (PDF) |
| 108 | Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer | 3.1 | 8 | Citations (PDF) |
| 109 | COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic | 3.0 | 15 | Citations (PDF) |
| 110 | Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer | 3.0 | 3 | Citations (PDF) |
| 111 | Surgical Complications and Hospital Costs in Robot-Assisted Versus Conventional Laparoscopic Hysterectomy With Concurrent Sacrocolpopexy: Analysis of the Nationwide Readmissions Database | 1.3 | 10 | Citations (PDF) |
| 112 | Nationwide Estimates of Annual Inpatient and Outpatient Hysterectomies Performed in the United States | 1.9 | 50 | Citations (PDF) |
| 113 | Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer | 3.0 | 10 | Citations (PDF) |
| 114 | Hormonal therapy or chemotherapy for early-stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study | 3.0 | 4 | Citations (PDF) |
| 115 | Outcomes during delivery hospitalisations with inflammatory bowel disease | 3.1 | 8 | Citations (PDF) |
| 116 | Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent U.S. trends | 0.9 | 13 | Citations (PDF) |
| 117 | Safety Warning about Laparoscopic Power Morcellation in Hysterectomy: A Cost-Effectiveness Analysis of National Impact | 1.0 | 2 | Citations (PDF) |
| 118 | Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis | 1.9 | 1 | Citations (PDF) |
| 119 | Pathologic characteristics, patterns of care, and outcomes of Asian-Americans and Pacific islanders with uterine cancer | 3.0 | 7 | Citations (PDF) |
| 120 | Trends in human papillomavirus vaccination among women aged 27 to 45 years, from 2017 to 2019 | 2.4 | 0 | Citations (PDF) |
| 121 | Association between hospital treatment volume and major complications in ovarian hyperstimulation syndrome | 0.9 | 0 | Citations (PDF) |
| 122 | Patterns of cervical cancer screening among Medicaid beneficiaries | 3.1 | 3 | Citations (PDF) |
| 123 | Cancer-Specific Mortality in Asian American Women Diagnosed with Gynecologic Cancer: A Nationwide Population-Based Analysis | 1.1 | 7 | Citations (PDF) |
| 124 | Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States | 2.4 | 15 | Citations (PDF) |
| 125 | Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: Systematic review and meta-analysis. | 3.0 | 8 | Citations (PDF) |
| 126 | Adjuvant and first line chemotherapy use for endometrial cancer | 0.7 | 12 | Citations (PDF) |
| 127 | Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer | 1.9 | 23 | Citations (PDF) |
| 128 | Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrum | 2.1 | 6 | Citations (PDF) |
| 129 | New persistent opioid use among adolescents and young adults with sarcoma | 4.0 | 13 | Citations (PDF) |
| 130 | Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform | 3.0 | 7 | Citations (PDF) |
| 131 | Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery | 1.9 | 8 | Citations (PDF) |
| 132 | Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer | 2.7 | 12 | Citations (PDF) |
| 133 | Assessment of Severe Maternal Morbidity and Mortality in Pregnancies Complicated by Cancer in the US | 14.4 | 26 | Citations (PDF) |
| 134 | Association between immigrant status and advanced cancer patients' location and quality of death | 4.0 | 9 | Citations (PDF) |
| 135 | Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery | 4.0 | 3 | Citations (PDF) |
| 136 | Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer | 3.0 | 7 | Citations (PDF) |
| 137 | Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis | 3.7 | 32 | Citations (PDF) |
| 138 | Malignant peritoneal cytology in endometrial cancer: a contemporary review | 2.5 | 9 | Citations (PDF) |
| 139 | Utilization of lymph node evaluation at hysterectomy for cervical carcinoma in situ | 1.5 | 3 | Citations (PDF) |
| 140 | Gynecologic oncologists in surgery for placenta accreta spectrum: a survey for practice, experience, and interest | 2.7 | 11 | Citations (PDF) |
| 141 | Factors Associated With Patients Not Receiving Oral Anticancer Drugs | 6.6 | 8 | Citations (PDF) |
| 142 | Obstetric outcomes among women with a liver transplant | 1.7 | 9 | Citations (PDF) |
| 143 | Patterns of care for women with placenta accreta spectrum | 1.7 | 10 | Citations (PDF) |
| 144 | Hospital Safety-Net Burden and Risk for Readmissions and Severe Maternal Morbidity | 1.7 | 5 | Citations (PDF) |
| 145 | Receipt of Proton-Pump Inhibitors during Pregnancy and Risk for Preeclampsia | 1.7 | 12 | Citations (PDF) |
| 146 | Postpartum hemorrhage and risk for postpartum readmission | 1.7 | 34 | Citations (PDF) |
| 147 | Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events | 3.0 | 17 | Citations (PDF) |
| 148 | The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis | 0.8 | 24 | Citations (PDF) |
| 149 | Less radical surgery for early-stage cervical cancer: a systematic review | 2.4 | 34 | Citations (PDF) |
| 150 | Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology | 2.4 | 14 | Citations (PDF) |
| 151 | Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy | 4.0 | 8 | Citations (PDF) |
| 152 | Cost of care for the initial management of cervical cancer in women with commercial insurance | 2.4 | 18 | Citations (PDF) |
| 153 | National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA | 2.6 | 13 | Citations (PDF) |
| 154 | Postpartum Psychiatric Admissions in the United States | 1.7 | 8 | Citations (PDF) |
| 155 | Surveillance in Older Women With Incidental Ovarian Cysts: Maximal Projected Benefits by Age and Comorbidity Level | 2.3 | 3 | Citations (PDF) |
| 156 | Quantitative analysis of abnormalities in gynecologic cytopathology with deep learning | 3.2 | 16 | Citations (PDF) |
| 157 | Inappropriateness of Proton Pump Inhibitors After Hospital Discharge Is Associated with Thirty-Day Hospital Readmission | 2.1 | 6 | Citations (PDF) |
| 158 | Association Between Adjuvant Therapy and Survival in Stage II–III Endometrial Cancer: Influence of Malignant Peritoneal Cytology | 2.3 | 12 | Citations (PDF) |
| 159 | Trends in Use of Myomectomy for the Surgical Management of Uterine Leiomyomas in Perimenopausal and Postmenopausal Women | 1.9 | 3 | Citations (PDF) |
| 160 | Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States | 3.0 | 27 | Citations (PDF) |
| 161 | Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014 | 6.6 | 30 | Citations (PDF) |
| 162 | Uptake and Outcomes of Sentinel Lymph Node Mapping in Women With Atypical Endometrial Hyperplasia | 1.9 | 28 | Citations (PDF) |
| 163 | Racial and Ethnic Disparities in Peripartum Hysterectomy Risk and Outcomes | 1.7 | 10 | Citations (PDF) |
| 164 | The effect of frailty on postoperative readmissions, morbidity, and mortality in endometrial cancer surgery | 3.0 | 22 | Citations (PDF) |
| 165 | Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic | 3.0 | 8 | Citations (PDF) |
| 166 | Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months | 2.1 | 2 | Citations (PDF) |
| 167 | Use of fertility preservation services in male reproductive-aged cancer patients | 0.7 | 13 | Citations (PDF) |
| 168 | Hospital variation in responses to safety warnings about power morcellation in hysterectomy | 2.4 | 4 | Citations (PDF) |
| 169 | Services and payer mix of Black-serving hospitals and related severe maternal morbidity | 2.4 | 5 | Citations (PDF) |
| 170 | Trends in ovarian conservation and association with survival in premenopausal patients with stage I leiomyosarcoma | 3.0 | 3 | Citations (PDF) |
| 171 | Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States | 2.4 | 36 | Citations (PDF) |
| 172 | Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States | 3.0 | 15 | Citations (PDF) |
| 173 | Fragmentation of surgery and chemotherapy in the initial phase of ovarian cancer care and its association with overall survival | 3.0 | 17 | Citations (PDF) |
| 174 | Disparities in Access to High-Volume Surgeons Within High-Volume Hospitals for Hysterectomy | 1.9 | 24 | Citations (PDF) |
| 175 | Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States | 3.0 | 30 | Citations (PDF) |
| 176 | Association between hysterectomy wait-time and all-cause mortality for micro-invasive cervical cancer: treatment implications during the coronavirus pandemic | 1.9 | 3 | Citations (PDF) |
| 177 | Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer | 1.9 | 8 | Citations (PDF) |
| 178 | Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance | 3.0 | 16 | Citations (PDF) |
| 179 | Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care | 3.0 | 50 | Citations (PDF) |
| 180 | Physician attitudes and knowledge on prophylactic salpingectomy in perimenopausal patients | 0.7 | 8 | Citations (PDF) |
| 181 | Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome | 6.6 | 14 | Citations (PDF) |
| 182 | Adherence to PARP inhibitor therapy among women with ovarian cancer | 3.0 | 10 | Citations (PDF) |
| 183 | Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer | 14.4 | 38 | Citations (PDF) |
| 184 | Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis | 2.4 | 45 | Citations (PDF) |
| 185 | Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer | 3.0 | 8 | Citations (PDF) |
| 186 | Secondary haematologic malignancies in women with ovarian cancer receiving poly-ADP ribose polymerase inhibitor therapy | 4.9 | 5 | Citations (PDF) |
| 187 | Trends in the Use of Minimally Invasive Adnexal Surgery in the United States | 1.9 | 11 | Citations (PDF) |
| 188 | Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review | 0.7 | 24 | Citations (PDF) |
| 189 | Preeclampsia outcomes at delivery and race | 1.7 | 77 | Citations (PDF) |
| 190 | Oral Opioid Use during Vaginal Delivery Hospitalizations | 1.7 | 1 | Citations (PDF) |
| 191 | Postpartum length of stay and risk for readmission among women with preeclampsia | 1.7 | 42 | Citations (PDF) |
| 192 | Effect of regionalization of endometrial cancer care on site of care and patient travel | 2.4 | 12 | Citations (PDF) |
| 193 | Fragmentation of postoperative care after surgical management of ovarian cancer at 30 days and 90 days | 2.4 | 21 | Citations (PDF) |
| 194 | Opioid Use Disorder during Antepartum and Postpartum Hospitalizations | 1.7 | 9 | Citations (PDF) |
| 195 | Maternal Age and Preeclampsia Outcomes during Delivery Hospitalizations | 1.7 | 35 | Citations (PDF) |
| 196 | Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases | 6.0 | 62 | Citations (PDF) |
| 197 | Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone | 2.4 | 19 | Citations (PDF) |
| 198 | Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events | 4.0 | 19 | Citations (PDF) |
| 199 | Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models | 3.0 | 4 | Citations (PDF) |
| 200 | Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies | 1.5 | 22 | Citations (PDF) |
| 201 | Reply | 2.4 | 0 | Citations (PDF) |
| 202 | Effect of frailty on postoperative readmissions and cost of care for ovarian cancer | 3.0 | 33 | Citations (PDF) |
| 203 | Intradepartmental redeployment of faculty and staff | 2.3 | 2 | Citations (PDF) |
| 204 | Toxicity after adjuvant therapy for stage III uterine cancer | 3.0 | 4 | Citations (PDF) |
| 205 | Using machine learning to create prognostic systems for endometrial cancer | 3.0 | 40 | Citations (PDF) |
| 206 | Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period | 3.0 | 16 | Citations (PDF) |
| 207 | Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection | 3.0 | 10 | Citations (PDF) |
| 208 | Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer | 3.0 | 40 | Citations (PDF) |
| 209 | COVID‐19 outcomes of patients with gynecologic cancer in New York City | 4.0 | 56 | Citations (PDF) |
| 210 | Associations Between Built Environment, Neighborhood Socioeconomic Status, and SARS-CoV-2 Infection Among Pregnant Women in New York City | 16.6 | 156 | Citations (PDF) |
| 211 | Trends in venous thromboembolism prophylaxis in gynecologic surgery for benign and malignant indications | 1.9 | 4 | Citations (PDF) |
| 212 | Insurance-Associated Disparities in Opioid Use and Misuse Among Patients Undergoing Gynecologic Surgery for Benign Indications | 1.9 | 11 | Citations (PDF) |
| 213 | The Volume-Outcome Paradigm for Gynecologic Surgery: Clinical and Policy Implications | 1.2 | 21 | Citations (PDF) |
| 214 | Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic | 4.9 | 10 | Citations (PDF) |
| 215 | Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 | 6.6 | 43 | Citations (PDF) |
| 216 | Triple stimulation (TriStim) before bilateral oophorectomy in a young woman with ovarian cancer: a case report and review of the literature | 3.8 | 5 | Citations (PDF) |
| 217 | The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer | 3.0 | 28 | Citations (PDF) |
| 218 | Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes | 3.0 | 16 | Citations (PDF) |
| 219 | Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes | 3.0 | 14 | Citations (PDF) |
| 220 | Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer | 14.4 | 181 | Citations (PDF) |
| 221 | Minimally Invasive Surgery and Risk of Capsule Rupture for Women With Early-Stage Ovarian Cancer | 14.4 | 56 | Citations (PDF) |
| 222 | Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study | 1.9 | 6 | Citations (PDF) |
| 223 | Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data | 2.4 | 12 | Citations (PDF) |
| 224 | When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic | 3.0 | 54 | Citations (PDF) |
| 225 | Maternal Race/Ethnicity, Hypertension, and Risk for Stroke During Delivery Admission | 4.0 | 72 | Citations (PDF) |
| 226 | Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer | 3.0 | 15 | Citations (PDF) |
| 227 | A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer | 3.0 | 10 | Citations (PDF) |
| 228 | Antibiotics for 3rd and 4th Degree Vaginal Lacerations, Uterine Tamponade, and Manual Placental Extraction | 1.7 | 2 | Citations (PDF) |
| 229 | Evolving population-based statistics for rare epithelial ovarian cancers | 3.0 | 27 | Citations (PDF) |
| 230 | Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States | 3.0 | 15 | Citations (PDF) |
| 231 | Fragmentation of postpartum readmissions in the United States | 2.4 | 24 | Citations (PDF) |
| 232 | Increasing NIH funding for academic departments of obstetrics and gynecology: a call to action | 2.4 | 26 | Citations (PDF) |
| 233 | Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer | 6.6 | 35 | Citations (PDF) |
| 234 | Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States | 1.9 | 4 | Citations (PDF) |
| 235 | The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States | 2.4 | 44 | Citations (PDF) |
| 236 | Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer | 4.9 | 47 | Citations (PDF) |
| 237 | Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer | 2.7 | 32 | Citations (PDF) |
| 238 | Reply | 2.4 | 0 | Citations (PDF) |
| 239 | Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation | 3.0 | 12 | Citations (PDF) |
| 240 | Factors Associated with Multidisciplinary Consultations in Patients with Early Stage Breast Cancer | 1.6 | 9 | Citations (PDF) |
| 241 | Use of fertility preservation services in female reproductive-aged cancer patients | 2.4 | 31 | Citations (PDF) |
| 242 | Safety of same-day discharge for minimally invasive hysterectomy for endometrial cancer | 2.4 | 24 | Citations (PDF) |
| 243 | Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer | 3.0 | 15 | Citations (PDF) |
| 244 | Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data | 2.6 | 6 | Citations (PDF) |
| 245 | Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer | 3.0 | 20 | Citations (PDF) |
| 246 | Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes | 3.0 | 22 | Citations (PDF) |
| 247 | Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model | 2.3 | 0 | Citations (PDF) |
| 248 | Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based Analysis | 2.5 | 3 | Citations (PDF) |
| 249 | Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis | 3.0 | 9 | Citations (PDF) |
| 250 | Postpartum readmissions among women with opioid use disorder | 2.1 | 14 | Citations (PDF) |
| 251 | Regionalization of care for women with ovarian cancer | 3.0 | 7 | Citations (PDF) |
| 252 | Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer | 8.8 | 8 | Citations (PDF) |
| 253 | Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally invasive surgery versus laparotomy | 2.4 | 37 | Citations (PDF) |
| 254 | Patterns of care and outcomes for women with uterine cancer and ovarian metastases | 2.7 | 4 | Citations (PDF) |
| 255 | Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy | 2.4 | 39 | Citations (PDF) |
| 256 | Substantial Increase in Anesthesia Assistance for Outpatient Colonoscopy and Associated Cost Nationwide | 6.0 | 35 | Citations (PDF) |
| 257 | Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer | 3.0 | 17 | Citations (PDF) |
| 258 | FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data | 2.6 | 65 | Citations (PDF) |
| 259 | Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research | 3.0 | 19 | Citations (PDF) |
| 260 | Maternal outcomes by race during postpartum readmissions | 2.4 | 59 | Citations (PDF) |
| 261 | Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer | 2.4 | 42 | Citations (PDF) |
| 262 | Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study | 3.0 | 57 | Citations (PDF) |
| 263 | Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines | 1.9 | 248 | Citations (PDF) |
| 264 | Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with <sup>18</sup>F-fluorodeoxyglucose–positron emission tomography in stage IB cervical cancer | 2.7 | 8 | Citations (PDF) |
| 265 | Use and Misuse of Opioids After Gynecologic Surgical Procedures | 1.9 | 59 | Citations (PDF) |
| 266 | Caring for Patients With Uterine Cancer in Rural and Public Hospitals in New York State | 1.9 | 2 | Citations (PDF) |
| 267 | Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer | 1.9 | 12 | Citations (PDF) |
| 268 | Antibiotic Use Without Indication During Delivery Hospitalizations in the United States | 1.9 | 11 | Citations (PDF) |
| 269 | Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer | 1.9 | 32 | Citations (PDF) |
| 270 | Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer | 1.9 | 11 | Citations (PDF) |
| 271 | Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer | 2.6 | 5 | Citations (PDF) |
| 272 | Trends in comorbidity, acuity, and maternal risk associated with preeclampsia across obstetric volume settings | 1.7 | 14 | Citations (PDF) |
| 273 | Patterns of seizure prophylaxis after oncologic neurosurgery | 2.5 | 34 | Citations (PDF) |
| 274 | Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model | 3.0 | 4 | Citations (PDF) |
| 275 | Postpartum Thromboembolism Prophylaxis during Delivery Hospitalizations | 1.7 | 14 | Citations (PDF) |
| 276 | Heparin-Induced Thrombocytopenia during Obstetric Hospital Admissions | 1.7 | 16 | Citations (PDF) |
| 277 | Use of Antihypertensive Medications During Delivery Hospitalizations Complicated by Preeclampsia | 1.9 | 44 | Citations (PDF) |
| 278 | Reply | 2.4 | 0 | Citations (PDF) |
| 279 | Racial disparities in young women with endometrial cancer | 3.0 | 57 | Citations (PDF) |
| 280 | Reply | 2.4 | 0 | Citations (PDF) |
| 281 | Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma | 1.6 | 14 | Citations (PDF) |
| 282 | Impact of hospital volume on racial disparities and outcomes for endometrial cancer | 3.0 | 22 | Citations (PDF) |
| 283 | Identifying modifiable and non-modifiable risk factors associated with prolonged length of stay after hysterectomy for uterine cancer | 3.0 | 5 | Citations (PDF) |
| 284 | Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP) | 3.0 | 8 | Citations (PDF) |
| 285 | The role of the vaginal microbiome in gynaecological cancer | 3.1 | 160 | Citations (PDF) |
| 286 | Risk for postpartum hemorrhage, transfusion, and hemorrhage-related morbidity at low, moderate, and high volume hospitals | 1.7 | 31 | Citations (PDF) |
| 287 | National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery | 2.7 | 23 | Citations (PDF) |
| 288 | Rectal balloon use limits vaginal displacement, rectal dose, and rectal toxicity in patients receiving IMRT for postoperative gynecological malignancies | 0.9 | 3 | Citations (PDF) |
| 289 | Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence | 3.0 | 18 | Citations (PDF) |
| 290 | Association Between Hospital Financial Distress and Immediate Breast Reconstruction Surgery After Mastectomy Among Women With Ductal Carcinoma In Situ | 8.8 | 10 | Citations (PDF) |
| 291 | Reply | 2.4 | 0 | Citations (PDF) |
| 292 | Educational Intervention to Improve Code Status Discussion Proficiency Among Obstetrics and Gynecology Residents | 1.6 | 10 | Citations (PDF) |
| 293 | Failure to Rescue and Mortality Following Resection of Intracranial Neoplasms | 2.0 | 19 | Citations (PDF) |
| 294 | Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy | 1.9 | 13 | Citations (PDF) |
| 295 | Maternal age and risk for adverse outcomes | 2.4 | 174 | Citations (PDF) |
| 296 | Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy vs hysterectomy | 2.4 | 24 | Citations (PDF) |
| 297 | Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers | 2.4 | 22 | Citations (PDF) |
| 298 | Trends and Outcomes Associated With Using Long-Acting Opioids During Delivery Hospitalizations | 1.9 | 18 | Citations (PDF) |
| 299 | Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer | 34.6 | 631 | Citations (PDF) |
| 300 | Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study | 3.2 | 10 | Citations (PDF) |
| 301 | Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer | 3.0 | 5 | Citations (PDF) |
| 302 | Assessment of Electronic Alert to Reduce Overuse of Granulocyte Colony-Stimulating Factor in Patients Hospitalized for Febrile Neutropenia | 14.4 | 2 | Citations (PDF) |
| 303 | Postpartum hemorrhage outcomes and race | 2.4 | 123 | Citations (PDF) |
| 304 | Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons | 1.9 | 60 | Citations (PDF) |
| 305 | Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions | 2.4 | 26 | Citations (PDF) |
| 306 | Postpartum venous thromboembolism readmissions in the United States | 2.4 | 36 | Citations (PDF) |
| 307 | Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis | 3.0 | 17 | Citations (PDF) |
| 308 | Patient reported outcomes in evaluation of chemotherapy toxicity in women with gynecologic malignancies: A pilot study | 3.0 | 9 | Citations (PDF) |
| 309 | Trends in Use and Survival Associated With Fertility-Sparing Trachelectomy for Young Women With Early-Stage Cervical Cancer | 1.9 | 37 | Citations (PDF) |
| 310 | Association Between Temporal Changes in Neonatal Mortality and Spontaneous and Clinician-Initiated Deliveries in the United States, 2006-2013 | 8.6 | 28 | Citations (PDF) |
| 311 | Utilization of ovarian transposition for fertility preservation among young women with pelvic malignancies who undergo radiotherapy | 2.4 | 12 | Citations (PDF) |
| 312 | Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer | 1.9 | 28 | Citations (PDF) |
| 313 | Regional Market Competition and the Use of Immediate Breast Reconstruction After Mastectomy | 2.3 | 11 | Citations (PDF) |
| 314 | Quality of Postoperative Venous Thromboembolism Prophylaxis in Neuro-oncologic Surgery | 2.0 | 14 | Citations (PDF) |
| 315 | Attitudes and Beliefs Regarding the Utility of Robotically Assisted Gynecologic Surgery Among Practicing Gynecologists | 0.9 | 7 | Citations (PDF) |
| 316 | Port Site Metastases: A Survey of the Society of Gynecologic Oncology and Commentary on the Clinical Workup and Management of Port Site Metastases | 0.8 | 6 | Citations (PDF) |
| 317 | Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome | 3.1 | 55 | Citations (PDF) |
| 318 | Physicians' Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women | 1.6 | 26 | Citations (PDF) |
| 319 | Utilization of sentinel lymph node biopsy for uterine cancer | 2.4 | 25 | Citations (PDF) |
| 320 | The role of maternal age in twin pregnancy outcomes | 2.4 | 62 | Citations (PDF) |
| 321 | Disparities in the management of ectopic pregnancy | 2.4 | 50 | Citations (PDF) |
| 322 | Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies | 1.6 | 10 | Citations (PDF) |
| 323 | Trends in operative vaginal delivery, 2005–2013: a population‐based study | 3.1 | 107 | Citations (PDF) |
| 324 | Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas | 4.3 | 59 | Citations (PDF) |
| 325 | Case 16-2017 — A 69-Year-Old Woman with Urinary Incontinence | 34.6 | 0 | Citations (PDF) |
| 326 | Sexual and Marital Dysfunction in Women With Gynecologic Cancer | 2.7 | 33 | Citations (PDF) |
| 327 | Patterns of Specialty-Based Referral and Perioperative Outcomes for Women With Endometrial Cancer Undergoing Hysterectomy | 1.9 | 39 | Citations (PDF) |
| 328 | Utility of radiation therapy for early-stage uterine papillary serous carcinoma | 3.0 | 32 | Citations (PDF) |
| 329 | Utilization of gynecologic services in women with breast cancer receiving hormonal therapy | 2.4 | 10 | Citations (PDF) |
| 330 | Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma | 4.0 | 114 | Citations (PDF) |
| 331 | Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States | 14.4 | 127 | Citations (PDF) |
| 332 | Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer | 3.0 | 41 | Citations (PDF) |
| 333 | Surgical Antibiotic Prophylaxis and Risk for Postoperative Antibiotic-Resistant Infections | 0.7 | 57 | Citations (PDF) |
| 334 | All-cause mortality in young women with endometrial cancer receiving progesterone therapy | 2.4 | 42 | Citations (PDF) |
| 335 | Trends in end-of-life care and health care spending in women with uterine cancer | 2.4 | 22 | Citations (PDF) |
| 336 | Association between survival time with metastatic breast cancer and aggressive end-of-life care | 2.4 | 30 | Citations (PDF) |
| 337 | Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer | 1.9 | 58 | Citations (PDF) |
| 338 | Venous Thromboembolism Prophylaxis During Antepartum Admissions and Postpartum Readmissions | 1.9 | 13 | Citations (PDF) |
| 339 | Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer | 1.9 | 35 | Citations (PDF) |
| 340 | Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer | 2.4 | 20 | Citations (PDF) |
| 341 | Comparative Effectiveness of Cancer Control and Survival after Robot-Assisted versus Open Radical Prostatectomy | 4.2 | 62 | Citations (PDF) |
| 342 | Serious maternal complications in relation to severe pre‐eclampsia: a retrospective cohort study of the impact of hospital volume | 3.1 | 26 | Citations (PDF) |
| 343 | Using publicly reported hospital data to predict obstetric quality | 1.7 | 2 | Citations (PDF) |
| 344 | Severe maternal morbidity and comorbid risk in hospitals performing <1000 deliveries per year | 2.4 | 35 | Citations (PDF) |
| 345 | Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010 | 3.1 | 253 | Citations (PDF) |
| 346 | Laparoscopic staging for apparent stage I epithelial ovarian cancer | 2.4 | 51 | Citations (PDF) |
| 347 | Inpatient Laparoscopic Hysterectomy in the United States: Trends and Factors Associated With Approach Selection | 0.8 | 44 | Citations (PDF) |
| 348 | Cost of Care for the Initial Management of Ovarian Cancer | 1.9 | 43 | Citations (PDF) |
| 349 | Practice Patterns, Attitudes, and Barriers to Palliative Care Consultation by Gynecologic Oncologists | 2.9 | 45 | Citations (PDF) |
| 350 | The modified frailty index and 30-day adverse events in oncologic neurosurgery | 2.5 | 99 | Citations (PDF) |
| 351 | Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer | 2.4 | 62 | Citations (PDF) |
| 352 | Axillary evaluation and lymphedema in women with ductal carcinoma in situ | 2.4 | 16 | Citations (PDF) |
| 353 | Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer | 1.9 | 33 | Citations (PDF) |
| 354 | Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors | 1.9 | 3 | Citations (PDF) |
| 355 | Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer | 1.9 | 61 | Citations (PDF) |
| 356 | Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer | 1.9 | 13 | Citations (PDF) |
| 357 | Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer | 1.9 | 23 | Citations (PDF) |
| 358 | Hospital variation in maternal complications following caesarean delivery in the United States: 2006–2012 | 3.1 | 10 | Citations (PDF) |
| 359 | Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynaecological surgery | 3.1 | 60 | Citations (PDF) |
| 360 | Epigenetic inactivation of TRAIL decoy receptors at 8p12‐21.3 commonly deleted region confers sensitivity to Apo2L/trail‐Cisplatin combination therapy in cervical cancer | 3.0 | 20 | Citations (PDF) |
| 361 | Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors | 2.9 | 38 | Citations (PDF) |
| 362 | Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer | 1.9 | 68 | Citations (PDF) |
| 363 | Gastroschisis: epidemiology and mode of delivery, 2005–2013 | 2.4 | 65 | Citations (PDF) |
| 364 | Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study | 2.1 | 93 | Citations (PDF) |
| 365 | Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients | 1.6 | 11 | Citations (PDF) |
| 366 | Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL) | 2.4 | 55 | Citations (PDF) |
| 367 | Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery | 3.0 | 23 | Citations (PDF) |
| 368 | Reply | 2.4 | 0 | Citations (PDF) |
| 369 | Use of Partial Nephrectomy after Acquisition of a Surgical Robot: A Population Based Study | 1.3 | 9 | Citations (PDF) |
| 370 | Hospital delivery volume, severe obstetrical morbidity, and failure to rescue | 2.4 | 60 | Citations (PDF) |
| 371 | Population-based risk for peripartum hysterectomy during low- and moderate-risk delivery hospitalizations | 2.4 | 18 | Citations (PDF) |
| 372 | National trends in total pelvic exenteration for gynecologic malignancies | 2.4 | 8 | Citations (PDF) |
| 373 | Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation | 16.6 | 42 | Citations (PDF) |
| 374 | Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients | 1.6 | 1 | Citations (PDF) |
| 375 | Utilization and Outcomes of Sentinel Lymph Node Biopsy for Vulvar Cancer | 1.9 | 21 | Citations (PDF) |
| 376 | Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998–2012 | 3.0 | 43 | Citations (PDF) |
| 377 | Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation | 0.8 | 48 | Citations (PDF) |
| 378 | Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer | 14.4 | 70 | Citations (PDF) |
| 379 | Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer | 3.0 | 64 | Citations (PDF) |
| 380 | Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis | 1.6 | 22 | Citations (PDF) |
| 381 | Natural history and outcome of neuroendocrine carcinoma of the cervix | 3.0 | 89 | Citations (PDF) |
| 382 | Effect of Regional Hospital Competition and Hospital Financial Status on the Use of Robotic-Assisted Surgery | 8.8 | 109 | Citations (PDF) |
| 383 | Applying to subspecialty fellowship: clarifying the confusion and conflicts! | 2.4 | 15 | Citations (PDF) |
| 384 | Comparative outcomes in older and younger women undergoing laparotomy or robotic surgical staging for endometrial cancer | 2.4 | 42 | Citations (PDF) |
| 385 | Underuse of BRCA testing in patients with breast and ovarian cancer | 2.4 | 32 | Citations (PDF) |
| 386 | Overuse of external beam radiotherapy for stage I endometrial cancer | 2.4 | 8 | Citations (PDF) |
| 387 | Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer | 14.4 | 93 | Citations (PDF) |
| 388 | Severe placental abruption: clinical definition and associations with maternal complications | 2.4 | 115 | Citations (PDF) |
| 389 | An economic analysis of trial of labor after cesarean delivery | 1.7 | 3 | Citations (PDF) |
| 390 | Population‐based assessment of determining predictors for quality of prostate cancer surveillance | 4.0 | 24 | Citations (PDF) |
| 391 | Trends in Relative Survival for Ovarian Cancer From 1975 to 2011 | 1.9 | 111 | Citations (PDF) |
| 392 | Factors Associated With 30-Day Hospital Readmission After Hysterectomy | 1.9 | 33 | Citations (PDF) |
| 393 | Complications Following Stereotactic Needle Biopsy of Intracranial Tumors | 1.5 | 152 | Citations (PDF) |
| 394 | Risk stratification and outcomes of women undergoing surgery for ovarian cancer | 3.0 | 46 | Citations (PDF) |
| 395 | Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy | 14.4 | 65 | Citations (PDF) |
| 396 | Influence of treatment center and hospital volume on survival for locally advanced cervical cancer | 3.0 | 58 | Citations (PDF) |
| 397 | High versus low-dose rate brachytherapy for cervical cancer | 3.0 | 25 | Citations (PDF) |
| 398 | Reply to A. Kolacevski et al | 2.9 | 0 | Citations (PDF) |
| 399 | Trends in Use and Safety of Image-Guided Transthoracic Needle Biopsies in Patients With Cancer | 2.9 | 26 | Citations (PDF) |
| 400 | The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ | 14.4 | 29 | Citations (PDF) |
| 401 | Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma | 3.0 | 35 | Citations (PDF) |
| 402 | Relationship Between Surgical Oncologic Outcomes and Publically Reported Hospital Quality and Satisfaction Measures | 4.6 | 15 | Citations (PDF) |
| 403 | Long-term mortality among women with epithelial ovarian cancer | 3.0 | 63 | Citations (PDF) |
| 404 | Quality and Outcomes of Treatment of Hypercalcemia of Malignancy | 1.6 | 42 | Citations (PDF) |
| 405 | Variation in and Factors Associated With Use of Episiotomy | 16.6 | 74 | Citations (PDF) |
| 406 | Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer | 3.0 | 18 | Citations (PDF) |
| 407 | Conservative management of morbidly adherent placenta: expert review | 2.4 | 186 | Citations (PDF) |
| 408 | Evaluation of Third-Degree and Fourth-Degree Laceration Rates as Quality Indicators | 1.9 | 120 | Citations (PDF) |
| 409 | Center of excellence for placenta accreta | 2.4 | 466 | Citations (PDF) |
| 410 | Population-level trends in relative survival for cervical cancer | 2.4 | 45 | Citations (PDF) |
| 411 | Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations | 2.4 | 38 | Citations (PDF) |
| 412 | Erythropoiesis-Stimulating Agent Use After Changes in Medicare Reimbursement Policies | 2.9 | 11 | Citations (PDF) |
| 413 | The Change From Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Early-Stage Breast Cancer | 4.6 | 93 | Citations (PDF) |
| 414 | Comparative Effectiveness of Robotically Assisted Compared With Laparoscopic Adnexal Surgery for Benign Gynecologic Disease | 1.9 | 20 | Citations (PDF) |
| 415 | Patterns of Use and Predictors of Receipt of Antibiotics in Women Undergoing Cesarean Delivery | 1.9 | 15 | Citations (PDF) |
| 416 | Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation | 16.6 | 134 | Citations (PDF) |
| 417 | Measure for Measure: The Cost of Improving Quality | 4.6 | 2 | Citations (PDF) |
| 418 | An Economic Analysis of Robotically Assisted Hysterectomy | 1.9 | 91 | Citations (PDF) |
| 419 | Utility of cell salvage in women undergoing abdominal myomectomy | 2.4 | 8 | Citations (PDF) |
| 420 | Safety and Tolerance of Radical Hysterectomy for Cervical Cancer in the Elderly | 3.0 | 26 | Citations (PDF) |
| 421 | Surgical management of placenta accreta: to leave or remove the placenta? | 3.1 | 59 | Citations (PDF) |
| 422 | Reply | 2.4 | 0 | Citations (PDF) |
| 423 | Patterns of use of hemostatic agents in patients undergoing major surgery | 1.6 | 64 | Citations (PDF) |
| 424 | Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer | 4.0 | 81 | Citations (PDF) |
| 425 | Fraction of cell‐free fetal DNA in the maternal serum as a predictor of abnormal placental invasion‐a pilot study | 2.3 | 32 | Citations (PDF) |
| 426 | Failure to rescue after major gynecologic surgery | 2.4 | 31 | Citations (PDF) |
| 427 | Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer | 3.0 | 81 | Citations (PDF) |
| 428 | Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome | 3.0 | 62 | Citations (PDF) |
| 429 | Patterns of care for locally advanced vulvar cancer | 2.4 | 12 | Citations (PDF) |
| 430 | Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer | 3.0 | 25 | Citations (PDF) |
| 431 | Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer | 3.0 | 126 | Citations (PDF) |
| 432 | Bowel obstruction in elderly ovarian cancer patients: A population-based study | 3.0 | 46 | Citations (PDF) |
| 433 | Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer | 3.0 | 23 | Citations (PDF) |
| 434 | Take 'em or leave 'em: Management of the ovaries in young women with endometrial cancer | 3.0 | 17 | Citations (PDF) |
| 435 | Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta | 1.7 | 56 | Citations (PDF) |
| 436 | Variation in Ovarian Conservation in Women Undergoing Hysterectomy for Benign Indications | 1.9 | 40 | Citations (PDF) |
| 437 | Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease | 16.6 | 504 | Citations (PDF) |
| 438 | Contemporary Clinical Management of Endometrial Cancer | 1.0 | 41 | Citations (PDF) |
| 439 | Prognostic Significance of Mucinous Differentiation of Endometrioid Adenocarcinoma of the Endometrium | 1.6 | 13 | Citations (PDF) |
| 440 | Comparison between emergent and elective delivery in women with placenta accreta | 1.7 | 28 | Citations (PDF) |
| 441 | Underuse of Postcesarean Thromboembolism Prophylaxis | 1.9 | 40 | Citations (PDF) |
| 442 | Incidence and Predictors of Bowel Obstruction in Elderly Patients With Stage IV Colon Cancer | 8.8 | 121 | Citations (PDF) |
| 443 | Deviations From Guideline-Based Therapy for Febrile Neutropenia in Cancer Patients and Their Effect on Outcomes | 10.5 | 104 | Citations (PDF) |
| 444 | Use of Guideline-Based Antibiotic Prophylaxis in Women Undergoing Gynecologic Surgery | 1.9 | 37 | Citations (PDF) |
| 445 | Nationwide Trends in the Performance of Inpatient Hysterectomy in the United States | 1.9 | 644 | Citations (PDF) |
| 446 | Trends in Hospital Volume and Patterns of Referral for Women With Gynecologic Cancers | 1.9 | 18 | Citations (PDF) |
| 447 | The Risk of Lymph Node Metastasis With Positive Peritoneal Cytology in Endometrial Cancer | 2.7 | 15 | Citations (PDF) |
| 448 | Nationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy | 2.3 | 27 | Citations (PDF) |
| 449 | NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype | 0.0 | 13 | Citations (PDF) |
| 450 | Reply to C.A. Hudis et al | 16.9 | 0 | Citations (PDF) |
| 451 | Uptake and Economic Impact of First-Cycle Colony-Stimulating Factor Use During Adjuvant Treatment of Breast Cancer | 16.9 | 27 | Citations (PDF) |
| 452 | Comparative effectiveness of robotic gynecologic surgery | 2.2 | 1 | Citations (PDF) |
| 453 | Comparative Effectiveness Research in Oncology Methodology: Observational Data | 16.9 | 132 | Citations (PDF) |
| 454 | Use and Benefits of Laparoscopic Hysterectomy for Stage I Endometrial Cancer Among Medicare Beneficiaries | 2.9 | 24 | Citations (PDF) |
| 455 | Acceptance and Compliance With Postpartum Human Papillomavirus Vaccination | 1.9 | 29 | Citations (PDF) |
| 456 | Effect of Radical Cytoreductive Surgery on Omission and Delay of Chemotherapy for Advanced-Stage Ovarian Cancer | 1.9 | 96 | Citations (PDF) |
| 457 | Effect of Surgical Volume on Outcomes for Laparoscopic Hysterectomy for Benign Indications | 1.9 | 127 | Citations (PDF) |
| 458 | Contemporary management of endometrial cancer | 62.3 | 255 | Citations (PDF) |
| 459 | Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer | 2.4 | 74 | Citations (PDF) |
| 460 | Comparative effectiveness of minimally invasive and abdominal radical hysterectomy for cervical cancer | 3.0 | 133 | Citations (PDF) |
| 461 | Re: Prognostic significance of adenocarcinoma histology in women with cervical cancer | 3.0 | 2 | Citations (PDF) |
| 462 | The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals | 2.4 | 57 | Citations (PDF) |
| 463 | Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy | 2.4 | 100 | Citations (PDF) |
| 464 | Patterns of care and treatment outcomes for elderly women with cervical cancer | 4.0 | 109 | Citations (PDF) |
| 465 | Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)‐positive and HIV‐negative patients with locally advanced cervical carcinoma in South Africa | 4.0 | 50 | Citations (PDF) |
| 466 | Microinvasive adenocarcinoma of the cervix | 2.4 | 34 | Citations (PDF) |
| 467 | Prognostic significance of adenocarcinoma histology in women with cervical cancer | 3.0 | 238 | Citations (PDF) |
| 468 | Defining the limits of radical cytoreductive surgery for ovarian cancer | 3.0 | 0 | Citations (PDF) |
| 469 | Trends in Surgical Mesh Use for Pelvic Organ Prolapse From 2000 to 2010 | 1.9 | 61 | Citations (PDF) |
| 470 | Risk and Predictors of Malignancy in Women with Endometrial Polyps | 2.3 | 54 | Citations (PDF) |
| 471 | Quality of Venous Thromboembolism Prophylaxis in Patients Undergoing Oncologic Surgery | 4.6 | 31 | Citations (PDF) |
| 472 | Quality of Perioperative Venous Thromboembolism Prophylaxis in Gynecologic Surgery | 1.9 | 17 | Citations (PDF) |
| 473 | Effect of Surgical Volume on Morbidity and Mortality of Abdominal Hysterectomy for Endometrial Cancer | 1.9 | 50 | Citations (PDF) |
| 474 | Transfusion requirements in obstetric patients with placenta accreta | 0.8 | 79 | Citations (PDF) |
| 475 | Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome | 3.0 | 68 | Citations (PDF) |
| 476 | High-grade uterine sarcoma during pregnancy | 3.0 | 4 | Citations (PDF) |
| 477 | Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer | 3.0 | 28 | Citations (PDF) |
| 478 | Defining the limits of radical cytoreductive surgery for ovarian cancer | 3.0 | 86 | Citations (PDF) |
| 479 | Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer | 2.4 | 20 | Citations (PDF) |
| 480 | Predictors of massive blood loss in women with placenta accreta | 2.4 | 118 | Citations (PDF) |
| 481 | Morbidity and mortality of surgery for endometrial cancer in the oldest old | 2.4 | 31 | Citations (PDF) |
| 482 | The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer | 2.4 | 45 | Citations (PDF) |
| 483 | Natural history and outcome of mucinous carcinoma of the ovary | 2.4 | 98 | Citations (PDF) |
| 484 | Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer | 2.4 | 63 | Citations (PDF) |
| 485 | Therapeutic role of lymphadenectomy for cervical cancer | 4.0 | 56 | Citations (PDF) |
| 486 | Management of Endometrial Cancer in Young Women | 1.2 | 21 | Citations (PDF) |
| 487 | Scientific Evidence Underlying the American College of Obstetricians and Gynecologists' Practice Bulletins | 1.9 | 69 | Citations (PDF) |
| 488 | Venous Thromboembolism and Use of Prophylaxis Among Women Undergoing Laparoscopic Hysterectomy | 1.9 | 53 | Citations (PDF) |
| 489 | Paclitaxel poliglumex for ovarian cancer | 3.9 | 58 | Citations (PDF) |
| 490 | Influence of Surgical Volume on Outcome for Laparoscopic Hysterectomy for Endometrial Cancer | 2.3 | 51 | Citations (PDF) |
| 491 | Uterine carcinosarcoma | 2.1 | 70 | Citations (PDF) |
| 492 | Fertility-Conserving Surgery for Young Women With Stage IA1 Cervical Cancer | 1.9 | 69 | Citations (PDF) |
| 493 | Peripartum Hysterectomy | 1.9 | 32 | Citations (PDF) |
| 494 | Comparative Performance of the 2009 International Federation of Gynecology and Obstetricsʼ Staging System for Uterine Corpus Cancer | 1.9 | 302 | Citations (PDF) |
| 495 | The Effect of Surgeon Volume on Outcomes and Resource Use for Vaginal Hysterectomy | 1.9 | 89 | Citations (PDF) |
| 496 | Long-term outcome and natural history of uterine adenosarcomas | 3.0 | 106 | Citations (PDF) |
| 497 | Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma | 4.0 | 50 | Citations (PDF) |
| 498 | Targeted Therapies in Epithelial Ovarian Cancer | 3.9 | 18 | Citations (PDF) |
| 499 | Regionalization of Care for Obstetric Hemorrhage and Its Effect on Maternal Mortality | 1.9 | 108 | Citations (PDF) |
| 500 | Morbidity and Mortality of Peripartum Hysterectomy | 1.9 | 129 | Citations (PDF) |
| 501 | Stage IIIA Endometrial Carcinoma | 1.9 | 19 | Citations (PDF) |
| 502 | Long-term assessment of bladder and bowel dysfunction after radical hysterectomy | 3.0 | 49 | Citations (PDF) |
| 503 | Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery | 3.0 | 64 | Citations (PDF) |
| 504 | Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation | 2.4 | 49 | Citations (PDF) |
| 505 | Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation | 2.4 | 107 | Citations (PDF) |
| 506 | Surgical Intervention in the Management of Postpartum Hemorrhage | 2.3 | 32 | Citations (PDF) |
| 507 | Racial disparities for uterine corpus tumors | 4.0 | 136 | Citations (PDF) |
| 508 | Fertility preservation in young women with epithelial ovarian cancer | 4.0 | 135 | Citations (PDF) |
| 509 | Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer | 3.0 | 63 | Citations (PDF) |
| 510 | Peritoneal Inclusion Cysts | 0.5 | 90 | Citations (PDF) |
| 511 | Improved survival for fallopian tube cancer | 4.0 | 66 | Citations (PDF) |
| 512 | Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression | 3.0 | 304 | Citations (PDF) |
| 513 | The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma | 2.4 | 81 | Citations (PDF) |
| 514 | Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival | 5.5 | 88 | Citations (PDF) |
| 515 | A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer | 2.7 | 39 | Citations (PDF) |
| 516 | Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer | 2.7 | 12 | Citations (PDF) |
| 517 | Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: A multi-institutional review | 3.0 | 99 | Citations (PDF) |
| 518 | The current and future role of screening in the era of HPV vaccination | 3.0 | 28 | Citations (PDF) |
| 519 | Clear cell carcinoma of the cervix: A multi-institutional review in the post-DES era | 3.0 | 90 | Citations (PDF) |
| 520 | Carboplatin dosing in obese women with ovarian cancer: A Gynecologic Oncology Group study | 3.0 | 58 | Citations (PDF) |
| 521 | The utility of preoperative endometrial sampling for the detection of uterine sarcomas | 3.0 | 138 | Citations (PDF) |
| 522 | The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies | 3.0 | 34 | Citations (PDF) |
| 523 | Clinical Indications for Human Papillomavirus Vaccination | 0.5 | 0 | Citations (PDF) |
| 524 | Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha | 29.2 | 107 | Citations (PDF) |
| 525 | Uterine Carcinosarcomas and Grade 3 Endometrioid Cancers | 1.9 | 115 | Citations (PDF) |
| 526 | Current treatment strategies for endometrial cancer | 2.5 | 12 | Citations (PDF) |
| 527 | Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy | 4.0 | 196 | Citations (PDF) |
| 528 | A vascular graft for endometrial cancer groin recurrence | 3.0 | 0 | Citations (PDF) |
| 529 | Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer☆ | 3.0 | 1 | Citations (PDF) |
| 530 | The impact of cervical cancer on quality of life—The components and means for management | 3.0 | 92 | Citations (PDF) |
| 531 | Uterine leiomyosarcomas | 0.0 | 0 | Citations (PDF) |
| 532 | Human Papillomavirus Triage for Young Women With Atypical Squamous Cells of Undetermined Significance | 1.9 | 18 | Citations (PDF) |
| 533 | Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery | 3.0 | 18 | Citations (PDF) |
| 534 | Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer | 3.0 | 87 | Citations (PDF) |
| 535 | Colposcopic accuracy of obstetrics and gynecology residents | 3.0 | 43 | Citations (PDF) |
| 536 | Cervical cancer prevention in the era of prophylactic vaccines: A preview for gynecologic oncologists | 3.0 | 42 | Citations (PDF) |
| 537 | Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma | 4.0 | 131 | Citations (PDF) |
| 538 | Cervical Dysplasia in Adolescents | 1.9 | 53 | Citations (PDF) |
| 539 | Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure | 2.4 | 38 | Citations (PDF) |
| 540 | Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma | 3.0 | 23 | Citations (PDF) |
| 541 | Cervical sarcomas: An analysis of incidence and outcome | 3.0 | 67 | Citations (PDF) |
| 542 | Cervical carcinoma in the elderly | 4.0 | 84 | Citations (PDF) |
| 543 | Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography | 4.0 | 170 | Citations (PDF) |
| 544 | Synchronous ovarian metastases at the time of laparotomy for colon cancer | 3.0 | 48 | Citations (PDF) |
| 545 | Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms | 3.0 | 27 | Citations (PDF) |
| 546 | A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? | 3.0 | 46 | Citations (PDF) |
| 547 | Morbidity of cytoreductive surgery in the elderly | 2.4 | 68 | Citations (PDF) |
| 548 | Is hypotonic dysfunctional labor associated with hypophosphatemia? | 2.4 | 0 | Citations (PDF) |
| 549 | Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies | 3.0 | 16 | Citations (PDF) |
| 550 | Acute abdominal pain with a calcified pelvic mass | 0.7 | 3 | Citations (PDF) |
| 551 | Treatment of High-Risk Gestational Trophoblastic Tumors | 1.2 | 19 | Citations (PDF) |
| 552 | Placental site trophoblastic tumor presenting with a pneumothorax during pregnancy | 1.9 | 11 | Citations (PDF) |
| 553 | Coordinate Regulation of Prostaglandin Metabolism for Induction of Parturition in Mice | 2.5 | 13 | Citations (PDF) |
| 554 | Diabetes Technology Use in Pregnancies with Type 1 Diabetes in the United States from 2009 to 2020 | 1.7 | 0 | Citations (PDF) |
| 555 | Emergency cesarean hysterectomy for placenta accreta spectrum: Estimation of maternal morbidity and mortality | 1.8 | 0 | Citations (PDF) |
| 556 | Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer | 14.4 | 6 | Citations (PDF) |
| 557 | Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol | 3.0 | 0 | Citations (PDF) |
| 558 | Physician variation in adopting opportunistic salpingectomy at the time of postpartum and interval sterilization for ovarian cancer risk reduction | 3.0 | 0 | Citations (PDF) |
| 559 | Physician Peer Influence on Salpingectomy Uptake for Tubal Sterilization and Ovarian Cancer Prevention | 6.6 | 1 | Citations (PDF) |
| 560 | Performance of ultrasound and rates of guideline-concordant care in a diverse postmenopausal bleeding cohort | 2.4 | 1 | Citations (PDF) |
| 561 | Population-Level Reduction in Ovarian Cancer Through Performance of Opportunistic Salpingectomy at the Time of Cholecystectomy | 4.6 | 0 | Citations (PDF) |
| 562 | Postmenopausal bleeding: Association of initial place of care with stage at diagnosis for uterine cancer | 3.0 | 0 | Citations (PDF) |
| 563 | Physician-level variability in adopting opportunistic salpingectomy for ovarian cancer prevention at the time of hysterectomy | 2.7 | 0 | Citations (PDF) |
| 564 | Disparities in delays and outcomes in patients with HER2-positive breast cancer | 2.4 | 0 | Citations (PDF) |
| 565 | Concerns in the Propensity Score–Matched Analysis—Reply | 14.4 | 0 | Citations (PDF) |
| 566 | Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial Cancer | 2.6 | 0 | Citations (PDF) |
